Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06370481 · ClinicalTrials.gov registry record · NA

HIV, Equity, and Addiction Training (HEAT) Program

A NA study of HIV and Opioid Use Disorder, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06370481: Recruiting NA study of HIV and Opioid Use Disorder, sponsored by University of Alabama at Birmingham.

NCT06370481 is a NA study of HIV and Opioid Use Disorder that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06370481, a NA study of HIV and Opioid Use Disorder, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

Primary Outcome

Follow up visit for care (either telemedicine or in person)

Interventions

  • OTHER Standard of care
  • OTHER Telemedicine

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-01-29
Est. Completion 2029-06
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06370481 shows while recruiting

NCT06370481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT06370481 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06370481 about?

NCT06370481 is a clinical study titled "HIV, Equity, and Addiction Training (HEAT) Program". This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

What is the current status of trial NCT06370481?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-01-29. Estimated completion is 2029-06.

What conditions does trial NCT06370481 study?

This clinical trial studies the following conditions: HIV, Opioid Use Disorder, Substance Use Disorders, Stimulant Use (Diagnosis).

What interventions are being tested in trial NCT06370481?

The interventions under investigation include: Standard of care (OTHER), Telemedicine (OTHER).

Who is sponsoring clinical trial NCT06370481?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06370481 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06370481's enrollment target sits among peer trials

30 264th of 303 higher than 31 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06370481, the US trial registry maintained by the National Library of Medicine. NCT06370481 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.